The tetrahydrobiopterin pathway: a novel target for the treatment of depression

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.12, 2011-12, pp. : 1625-1627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

By Grigoriadis Dimitri E

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 651-684

Informa Healthcare

Access to resources Recommend Favorite

The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

Tetrahydrobiopterin Pathway may Provide Novel Molecular Targets for Acute and Long Term Efficacy of Mood-Regulating Drugs

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 3, 2010-09 ,pp. : 174-181

Bentham Science Publishers

Access to resources Recommend Favorite

Disorders of Tetrahydrobiopterin Metabolism and their Treatment

Current Drug Metabolism, Vol. 3, Iss. 2, 2002-04 ,pp. : 123-131

Bentham Science Publishers

Access to resources Recommend Favorite

The Adiponectin Signaling Pathway as a Novel Pharmacological Target

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 12, 2006-12 ,pp. : 1331-1340

Bentham Science Publishers

Access to resources Recommend Favorite